fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Fluorometholone

All products: general benefit

FML · DIN 00247855 · 0.1% · Oph suspension

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
FML · DIN 00247855 Manufacturer: Allergan Inc.; listing date 1996-10-01 Health Canada: Marketed since 2024-03-28 · brand FML · ATC S01BA07 FLUOROMETHOLONE · form Suspension · route Ophthalmic · ingredients FLUOROMETHOLONE 0.1 %/W/V · company Abbvie corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

FML: Formulary list price $3.69 per unit (the source does not state the unit; exact figure $3.6858). What the ministry pays, not the patient.

Ministry pays: $3.6858 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00247855)

Source record
DIN 00247855: FML Raw flags: sec3=Y Item: 520800021; group id 594; item number 1553; lccId None; manufacturer id ALL Source form: Oph Susp; strength: 0.1% Recorded listing: General benefit Source prices (unrounded): $3.6858; ministry $3.6858 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00247855 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1470
Shortage status: active shortage (reported September 9, 2026, estimated to end October 23, 2026, last updated October 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00247855
Shortage record checked October 6, 2026

Other products in the same Health Canada class (S01B, S01BA): coverage varies; not interchangeable

  • Dexamethasone (Maxidex): general benefit
  • Prednisolone (Pred Forte): general benefit, not a benefit
  • Ketorolac tromethamine (Acular): general benefit
  • Bromfenac (Prolensa): not a benefit

Fluorometholone acetate

All products: general benefit

Flarex · DIN 00756784 · 0.1% · Oph suspension

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-20 — choose a marketed DIN from the same-category list.Discontinued March 20, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-20 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-03-20 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Flarex · DIN 00756784 Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01 Health Canada: Cancelled post market since 2025-03-20 · brand FLAREX · ATC S01BA07 FLUOROMETHOLONE · form Suspension · route Ophthalmic · ingredients FLUOROMETHOLONE ACETATE 0.1 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Flarex: Formulary list price $2.02 per unit (the source does not state the unit; exact figure $2.0240). What the ministry pays, not the patient.

Ministry pays: $2.0240 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00756784)

Source record
DIN 00756784: Flarex Raw flags: sec3=Y Item: 520800026; group id 595; item number 1554; lccId None; manufacturer id NOV Source form: Oph Susp; strength: 0.1% Recorded listing: General benefit Source prices (unrounded): $2.0240; ministry $2.0240 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00756784 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8229
Shortage status: discontinued (September 9, 2024, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00756784
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 20, 2025 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (S01B, S01BA): coverage varies; not interchangeable

  • Dexamethasone (Maxidex): general benefit
  • Prednisolone (Pred Forte): general benefit, not a benefit
  • Ketorolac tromethamine (Acular): general benefit
  • Bromfenac (Prolensa): not a benefit
Other drugs in the same formulary class (52:08 Anti-Inflammatory Agents) and how they are covered

Matched class: 52:08 Anti-Inflammatory Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DEXAMETHASONE, FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN, KETOROLAC TROMETHAMINE, LODOXAMIDE TROMETHAMINE Some products covered without a code (check the product listing): BECLOMETHASONE DIPROPIONATE, BUDESONIDE, PREDNISOLONE ACETATE 52:08 Anti-Inflammatory Agents

DEXAMETHASONE

· 2 products · General benefit · strengths: 0.1% · Oph Oint-3.5g Pk, Oph Susp

PREDNISOLONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Oph Susp

KETOROLAC TROMETHAMINE

· 3 products · General benefit · strengths: 0.5%, 0.45% w/v · Oph Sol, Oph Sol-0.4mL Vial Pk (Preservative-Free)

BROMFENAC

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.07% w/v · Oph Sol (With Preservative)

BECLOMETHASONE DIPROPIONATE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 50mcg · Nas-Sp-200 Dose Pk

BUDESONIDE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 64mcg/Metered Dose, 100mcg/Metered Dose · Nas Sp-120 Dose Pk, Nas Sp-165 Dose Pk

FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN

· 1 products · General benefit · strengths: 0.02% & 1% · Ot Sol

LODOXAMIDE TROMETHAMINE

· 1 products · General benefit · strengths: 0.1% · Oph Sol

AZELASTINE HCL & FLUTICASONE PROPIONATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 137mcg/Actuation&50mcg/Actuation · Nas-Sp-120 Dose Pk

FLUTICASONE PROPIONATE

· 4 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Actuation · Nas Sp-120 Dose Pk

MOMETASONE FUROATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Dose · Nas Sp-140 Dose Pk

TRIAMCINOLONE ACETONIDE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 55mcg/Metered Dose · Nas Sp-120 Dose Pk (with Preservative) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 52:08 and 1 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors, 52:36 Other Eye, Ear, Nose and Throat Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS FML® (fluorometholone) is indicated for: • the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. 1.1 Pediatrics (<18 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 1.2 Geriatrics (>65 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use. https://pdf.hres.ca/dpd_pm/00076578.PDF PM date: OCT 30, 1972 Source product: FML; DIN 00247855; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found

Availability

FML · DIN 00247855 Shortage status: active shortage (reported 2026-09-09, estimated to end 2026-10-23, last updated 2026-10-05); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00247855

Check this DIN again

Flarex · DIN 00756784 Shortage status: discontinued (2024-09-09, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00756784

Check this DIN again